Tex. Gov't Code Section 549.0151
Certain Prescription Drug Information Confidential

(a)

Notwithstanding any other state law other than Sections 549.0152 (General Prescription Drug Information Not Confidential; Exception) and 549.0153 (Existence or Nonexistence of Supplemental Rebate Agreement Not Confidential), information the commission obtains or maintains regarding prescription drug rebate negotiations or a supplemental Medicaid or other rebate agreement, including trade secrets, rebate amount, rebate percentage, and manufacturer or labeler pricing, is confidential and not subject to disclosure under Chapter 552 (Public Information).

(b)

Information that is confidential under Subsection (a) includes information described by that subsection that the commission obtains or maintains in connection with:

(1)

the vendor drug program;

(2)

the child health plan program;

(3)

the kidney health care program;

(4)

the children with special health care needs program; or

(5)

another state program the commission or a health and human services agency administers.
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.

Source: Section 549.0151 — Certain Prescription Drug Information Confidential, https://statutes.­capitol.­texas.­gov/Docs/GV/htm/GV.­549.­htm#549.­0151 (accessed Jun. 5, 2024).

549.0001
Bulk Purchasing with Another State of Prescription Drugs and Other Medications 549.0002
Value-based Arrangement in Medicaid Vendor Drug Program 549.0003
Period of Validity of Prescriptions Under Medicaid 549.0004
Certain Medications for Sex Offenders Prohibited 549.0005
Prior Approval of and Pharmacy Provider Access to Certain Communications with Certain Recipients and Enrollees 549.0051
Periodic Review of Vendor Drug Program Purchases 549.0052
Medicaid Prescription Drug Use and Expenditure Patterns 549.0101
Definitions 549.0102
Requirement to Negotiate for Supplemental Rebates for Certain Programs 549.0103
Voluntary Negotiation for Manufacturer and Labeler Supplemental Rebates 549.0104
Considerations in Supplemental Rebate Negotiations 549.0105
Required Disclosures in Negotiations for Supplemental Rebates 549.0106
Program Benefits Instead of Supplemental Rebates 549.0107
Limitations on Agreement to Accept Program Benefits Instead of Supplemental Rebates 549.0108
Treatment of Program Benefits for Certain Purposes 549.0151
Certain Prescription Drug Information Confidential 549.0152
General Prescription Drug Information Not Confidential 549.0153
Existence or Nonexistence of Supplemental Rebate Agreement Not Confidential 549.0201
Definition 549.0202
Preferred Drug Lists Required for Medicaid Vendor Drug and Child Health Plan Programs 549.0203
Preferred Drug Lists Authorized for Certain Programs 549.0204
Limitation on Drugs Included on Preferred Drug Lists 549.0205
Considerations for Including Drug on Preferred Drug Lists 549.0206
Submission of Evidence to Support Including Drug on Preferred Drug Lists 549.0207
Publication of Information Relating to and Distribution of Preferred Drug Lists 549.0251
Drugs Subject to Prior Authorization Requirements 549.0252
Prior Authorization and Certain Protocol Requirements Prohibited for Certain Antiretroviral Drugs 549.0253
Prior Authorization Prohibited for Certain Nonpreferred Antipsychotic Drugs 549.0254
Administration of Prior Authorization Requirements 549.0255
Prerequisite to Implementing Prior Authorization Requirement for Certain Drugs 549.0256
Notice of Prior Authorization Requirement Implementation and Procedures 549.0257
Prior Authorization Procedures 549.0258
Prior Authorization Automation and Point-of-sale Requirements 549.0259
Applicability of Prior Authorization Requirements to Prior Prescriptions 549.0260
Appeal of Prior Authorization Denial Under Medicaid Vendor Drug Program 549.0301
Definition 549.0302
Board Composition 549.0303
Conflicts of Interest 549.0304
Board Member Terms 549.0305
Presiding Officer 549.0306
Inapplicability of Other Law to Board 549.0307
Administrative Support for Board 549.0308
Rules for Board Operation 549.0309
General Powers and Duties of Board 549.0310
Board Meetings 549.0311
Board Summary of Certain Information Required 549.0312
Public Disclosure of Certain Board Recommendations Required 549.0351
Definitions 549.0352
Drug Use Reviews 549.0353
Annual Report 549.0401
Definition 549.0402
Provision of Program Information by Pharmaceutical Company 549.0403
Public Access to Program Information 549.0451
Development and Implementation of State Prescription Drug Program 549.0452
Program Eligibility 549.0453
Rules 549.0454
Generic Equivalent Authorized 549.0455
Program Funding and Funding Priorities
Green check means up to date. Up to date

Accessed:
Jun. 5, 2024

§ 549.0151’s source at texas​.gov